top of page
AI pixabay huge.jpg

Huma receives world’s first and only multi-condition EU MDR Class IIb regulatory approval

Huma’s platform is ready to use, reducing the time and cost for other companies to bring regulated SaMD products to market, democratising digital health innovation across the industry

Class IIb certification expands the patient population and level of disease severity that can be managed; allowing delivery of personalised care through the use of predictive algorithms

Clinical evidence from over 20 peer-reviewed publications and studies were submitted for regulatory assessment of clinical safety and efficacy





Comments


bottom of page